Analysis of the level of expression of pancytokeratins in epithelial and granulocellular tumors of the ovaries.
DOI:
https://doi.org/10.26641/2307-0404.2018.2.133693Keywords:
epithelial ovarian tumors, granulo-cellular tumors, immunohistochemistryAbstract
Differential diagnosis of ovarian neoplasms is carried out among groups of epithelial and granulocellular tumors and remains an actual problem of oncogynecology. In general, epithelial tumors occur (up to 60%), but granulocellular cell tumors account for up to 5% of all ovarian neoplasia. Materials and methods. A retrospective study of 43 observations of ovarian tumor lesions over the period of January-December 2017 was conducted in the work. The aim of the study was to analyze the complex of morphological and immunohistochemical characteristics of Cytokeratin, Pan AE1 / AE3 - negative phenotypes and Cytokeratin, Pan AE1 / AE3 - positive phenotypes of ovarian neoplasia to improve diagnostic algorithms. Results. The phenotype of epithelial ovarian tumors in 100% of observations corresponds to pancytokeratin Cytokeratin, Pan AE1 / AE3 "+", in its turn the phenotype of granulocellular tumors basically responded to expression of the Cytokeratin marker, Pan AE1 / AE3 "-" in 62.5%; and the variant in the part of the cells "+" / "-" Cytokeratin, Pan AE1 / AE3 was found in 37.5% of granulocellular tumors, regardless of their malignant potential. Thus, granulocellular tumors have variable expression of the Cytokeratin marker, Pan AE1 / AE3 and require the inclusion of other diagnostic IGH markers in the primary panel.
References
Pozharsky KM, Raskin GA, Vinokurov VL, Yurkova LE, Mukhina MS. [Immunohistochemical features of cells of serous ovarian adenocarcinoma, determining the clinical course of the disease and the survival of patients]. Arkhiv patologii. 2015;1:38-40. Russian.
Sachiko Kitamura, Kaoru Abiko, Noriomi Matsumura. Adult granulosa cell tumors of the ovary: a retrospective study of 30 cases with respect to the expression of steroid synthesis enzymes. Journal of Gynecologic Oncology. 2017;28(4):31-39.
Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;4:646-74.
Fletcher CDM. author. Diagnostic histopatology of tumors. PA: Elsevier. 2013;1:658-88.
Kurman RJ. Blaustein`s pathology of the female genital tract. Springer. 2001;791-904.
Mills SE, Carter D, Greenson JK. Diagnostic surgical pathology. Wolters Kluwer. 2010;2:2278-308.
Morikazu Miyamoto, Masashi Takano, Tadashi Aoyama. Seromucinous component in endometrioid endometrial carcinoma as a histological predictor of prognosis. Journal of Gynecologic Oncology. 2018;29(2):20-27.
Jiaheng Li, Riqiang Bao, Shiwei Peng The molecular mechanism of ovarian granulosa cell tumors. Journal of Ovarian Research. 2018;11:13-20.
Tummala M, et al. Recurrent ovarian cancer. Clinical Advances in Hematology and Oncology. 2005;3:723-36.
Kurman RJ, Carcangiu ML, Herrington CS, Young RH. WHO Classification of tumors of female reproductive organs. Revised 4th ed. Lyon, IARC. 2014;307.
Downloads
How to Cite
Issue
Section
License
Copyright (c) 2018 Medicni perspektivi (Medical perspectives)
This work is licensed under a Creative Commons Attribution 4.0 International License.
Submitting manuscript to the journal "Medicni perspektivi" the author(s) agree with transferring copyright from the author(s) to publisher (including photos, figures, tables, etc.) editor, reproducing materials of the manuscript in the journal, Internet, translation into other languages, export and import of the issue with the author’s article, spreading without limitation of their period of validity both on the territory of Ukraine and other countries. This and other mutual duties of the author and all co-authors separately and editorial board are secured by written agreement by special form to use the article, the sample of which is presented on the site.
Author signs a written agreement and sends it to Editorial Board simultaneously with submission of the manuscript.
